Gliclazide SR and Metformin SR ''"''"'''

Gliclazide SR and Metformin SR 
GLICLAGLAZE MET  are both medications commonly used in the management of type 2 diabetes. Each belongs to a different class of antidiabetic drugs, and they work in distinct ways to help control blood sugar levels. The "SR" designation indicates that these formulations are designed for sustained or extended release, providing a more gradual and prolonged effect compared to immediate-release formulations.
Gliclazide SR:
Class and Mechanism of Action:
Class: Sulfonylurea
Stimulates the release of insulin from the pancreas, helping to lower blood glucose levels. Gliclazide SR is a sustained-release formulation, providing a controlled release over time.
Metformin SR:
Class and Mechanism of Action:
Class: Biguanide
Reduces glucose production in the liver, improves insulin sensitivity in peripheral tissues, and decreases intestinal glucose absorption. Metformin SR is a sustained-release formulation, allowing for a gradual release of the medication.
Gliclazide SR: Used for the treatment of type 2 diabetes to improve glycemic control. It is typically prescribed when lifestyle modifications alone are insufficient.
Metformin SR: Commonly used as a first-line treatment for type 2 diabetes, often prescribed alongside diet and exercise. It helps improve insulin sensitivity and reduce glucose production.
GLICLAGLAZE MET  are sometimes prescribed together as part of combination therapy to address different aspects of glucose regulation. Combining medications with different mechanisms of action can enhance glycemic control.
Regular monitoring of blood glucose levels is important to assess the effectiveness of the medications.
Both medications have potential side effects, and individuals should be aware of symptoms such as hypoglycemia (more common with gliclazide) or gastrointestinal effects (more common with metformin).
Treatment plans, including the choice of medications and dosages, should be individualized based on the patient's health status, response to treatment, and potential side effects.
For further information please contact:
info@sterispharma.com
Order Now - https://www.sterisonline.com/product/gliclaglaze-met-133421